Access to gene therapy for rare diseases when commercialization is not fit for purpose
Thomas A. Fox, Juan A. Bueren, Fabio Candotti, Alain Fischer, Alessandro Aiuti, Arjan C. Lankester, The AGORA Initiative, Michael H. Albert, Maria Ester Bernardo, Marina Cavazzana, Stephan Ehl, Bénédicte Neven, J Prévot, Axel Schambach, Julián Sevilla, Adrian J. Thrasher, Robert Wynn, Claire Booth
Topics & Concepts
CommercializationGenetic enhancementGeneMedicineComputational biologyBiologyGeneticsBusinessMarketingCRISPR and Genetic EngineeringBiomedical Ethics and RegulationVirus-based gene therapy research